| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |